Takeda

Companies Takeda

News Takeda

• Takeda to Acquire LigoCyte Pharmaceuticals, Inc.

  Takeda Pharmaceutical Company Limited and LigoCyte Pharmaceuticals, Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and LigoCyte Pharmaceuticals, Inc. have entered into a definitive agreement for Takeda to acquire LigoCyte for an upfront payment of $60 mil more

• Takeda's Anti-Prostate Cancer Agent Orteronel(TAK-700) Enters into Phase III Clinical Trials in Japan

  The Takeda Oncology Company (“Millennium”) announced that Takeda Bio Development Center Limited (“Takeda Bio”) has initiated enrollment of patients in Japan for the two ongoing global Phase III clinical trials for the anti-prostate cancer investigational agent, orteronel(TAK-700).Orteronel, discover more

• Sanofi Tops Pfizer As Number One For Global Pharma Sales

  EvaluatePharma Ltd revealed that Sanofi is expected to take the top spot amongst the world’s pharmaceuticals manufacturers in 2012 and hold it through 2016. The French drug maker has raced up the rankings over the last decade largely through M&A activity, with the $20bn purchase this year of US biot more

Publications Takeda

• Translating the Genomics Revolution: The Need for an International Gene Therapy Consortium for Monogenic Diseases

  Translating the Genomics Revolution: The Need for an International Gene Therapy Consortium for Monogenic Diseases Molecular Therapy 21, 266 (February 2013). doi:10.1038/mt.2013.4 Authors: Jacques P Tremblay, Xiao Xiao, Annemieke Aartsma-Rus, Carlos Barbas, Helen M Blau, Adam more

• Effect of Environmental and Lifestyle Factors on Hypertension: Shimane COHRE Study

  by Tsuyoshi Hamano, Yoshinari Kimura, Miwako Takeda, Masayuki Yamasaki, Minoru Isomura, Toru Nabika, Kuninori Shiwaku Background In recent years there has been increasing evidence of an association between residential remoteness and hypertension (HTN); however, no study has examined the effects o more

• Clinical evaluation of sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsis

  Tsuboko Y, Takeda S, Mii S, Nakazato K, Tanaka K, Uchida E, Sakamoto A more

Market studies Takeda

• Japan Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: Japan’s pharmaceutical market is highly attractive to both foreign and local drugmakers. All three sub-sectors – patented, generic and over-the-counter (OTC) medicines – are large and forecast to growth over the medium term. Regulations are well-developed, transparent and improving. The ke more

• Brazil Pharmaceuticals and Healthcare Report Q4 2012

  BMI View: The Brazilian pharmaceutical market is still our favourite regional market in Latin America despite the recent downgrade in our Risk/Reward Ratings. The government has increasingly invested in the healthcare sector and pharmaceutical industry to stimulate local production capacity, reduce more

• Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion

  GBI Research, the leading business intelligence provider, has released its latest research “Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion”, which provides insights into the anti-hypertensives therapeutics market more

Websites Takeda